local neoplasm recurrence

Summary

Summary: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.

Top Publications

  1. ncbi Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
    M Clarke
    Clinical Trial Service Unit, Oxford, UK
    Lancet 366:2087-106. 2005
  2. ncbi Cancer of the ovary
    Stephen A Cannistra
    Program of Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    N Engl J Med 351:2519-29. 2004
  3. ncbi Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:1233-41. 2002
  4. ncbi Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
    Paul L Nguyen
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    J Clin Oncol 26:2373-8. 2008
  5. ncbi Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
    Cornelia Liedtke
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 1439, USA
    J Clin Oncol 26:1275-81. 2008
  6. ncbi Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Shinichi Sakuramoto
    Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    N Engl J Med 357:1810-20. 2007
  7. ncbi Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    Dieta Brandsma
    Department of Neuro Oncology, Daniel den Hoed Cancer Centre, Erasmus Medical Centre, Rotterdam, Netherlands
    Lancet Oncol 9:453-61. 2008
  8. ncbi Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
    E Shaw
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 47:291-8. 2000
  9. ncbi A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
    Shuichiro Shiina
    Department of Gastroenterology, University of Tokyo, Japan
    Gastroenterology 129:122-30. 2005
  10. ncbi Posttraumatic growth following breast cancer: a controlled comparison study
    M J Cordova
    Department of Psychology, University of Kentucky, USA
    Health Psychol 20:176-85. 2001

Research Grants

  1. Strategies Against HPV Related Genital Diseases in Women
    Bradley Monk; Fiscal Year: 2006
  2. Methodology of Phase I and II trials of anticancer CAM
    Andrew Vickers; Fiscal Year: 2004
  3. Biobehavioral Responses to Cancer
    BARBARA ANDERSEN; Fiscal Year: 2007
  4. Defibrotide for the treatment of severe hepatic veno-cc*
    Paul Richardson; Fiscal Year: 2007
  5. PSYCHOLOGICAL INTERVENTION FOR WOMEN WITH BREAST CANCER
    BARBARA ANDERSEN; Fiscal Year: 2005
  6. Phase II Study of 44Gy from 131I-81C6 for CNS Tumors
    David Reardon; Fiscal Year: 2004
  7. Human Breast Cancer Stem Cell Surrogates
    WENDY A contact WOODWARD; Fiscal Year: 2010
  8. Human Breast Cancer Stem Cell Surrogates
    Massimo Cristofanilli; Fiscal Year: 2009
  9. Human Breast Cancer Stem Cell Surrogates
    Massimo Cristofanilli; Fiscal Year: 2009
  10. Genetic and Epigenetic Markers in Ovarian Cancer
    Elizabeth Swisher; Fiscal Year: 2006

Detail Information

Publications247 found, 100 shown here

  1. ncbi Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
    M Clarke
    Clinical Trial Service Unit, Oxford, UK
    Lancet 366:2087-106. 2005
    ....
  2. ncbi Cancer of the ovary
    Stephen A Cannistra
    Program of Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    N Engl J Med 351:2519-29. 2004
  3. ncbi Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:1233-41. 2002
    ..In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer...
  4. ncbi Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
    Paul L Nguyen
    Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    J Clin Oncol 26:2373-8. 2008
    ..To determine whether breast cancer subtype is associated with outcome after breast-conserving therapy (BCT) consisting of lumpectomy and radiation therapy...
  5. ncbi Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
    Cornelia Liedtke
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 1439, USA
    J Clin Oncol 26:1275-81. 2008
    ..In this study, we compared response to neoadjuvant chemotherapy and survival between patients with TNBC and non-TNBC...
  6. ncbi Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Shinichi Sakuramoto
    Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan
    N Engl J Med 357:1810-20. 2007
    ..Advanced gastric cancer can respond to S-1, an oral fluoropyrimidine. We tested S-1 as adjuvant chemotherapy in patients with curatively resected gastric cancer...
  7. ncbi Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    Dieta Brandsma
    Department of Neuro Oncology, Daniel den Hoed Cancer Centre, Erasmus Medical Centre, Rotterdam, Netherlands
    Lancet Oncol 9:453-61. 2008
    ..Further research is needed to establish reliable imaging parameters that distinguish between true tumour progression and pseudoprogression or treatment-related necrosis...
  8. ncbi Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
    E Shaw
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 47:291-8. 2000
    ..To determine the maximum tolerated dose of single fraction radiosurgery in patients with recurrent previously irradiated primary brain tumors and brain metastases...
  9. ncbi A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
    Shuichiro Shiina
    Department of Gastroenterology, University of Tokyo, Japan
    Gastroenterology 129:122-30. 2005
    ..Percutaneous radiofrequency ablation is a recently introduced treatment for hepatocellular carcinoma, whereas ethanol injection is now a standard therapy. We compared their long-term outcomes...
  10. ncbi Posttraumatic growth following breast cancer: a controlled comparison study
    M J Cordova
    Department of Psychology, University of Kentucky, USA
    Health Psychol 20:176-85. 2001
    ..Research that has focused solely on detection of distress and its correlates may paint an incomplete and potentially misleading picture of adjustment to cancer...
  11. ncbi Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
    David S Alberts
    Department of Medicine, Arizona Cancer Center, College of Public Health, University of Arizona, Tucson, AZ, USA
    J Natl Cancer Inst 97:846-53. 2005
    ..We conducted a phase III, double-blind placebo-controlled trial of UDCA to evaluate its ability to prevent colorectal adenoma recurrence...
  12. ncbi Current treatment options in dermatofibrosarcoma protuberans
    Doreen Lemm
    Hämatologie Onkologie, Klinik fur Innere Medizin II, Universitatsklinikum Jena, Jena, Germany
    J Cancer Res Clin Oncol 135:653-65. 2009
    ..With Imatinib, a selective PDGFR tyrosin kinase inhibitor, partial and complete remissions of DFSP could be achieved. This article reviews the current opinion and literature about DFSP and resulting therapy strategies...
  13. ncbi A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy
    Joseph A Smith
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232 2765, USA
    J Urol 178:2385-9; discussion 2389-90. 2007
    ..We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic prostatectomy cases...
  14. ncbi Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis
    Marco Montorsi
    Department of General Surgery M M, P B, M D, E M, A s, University of Milano School of Medicine, Istituto Clinico Humanitas, Milano, Italy
    J Gastrointest Surg 9:62-7; discussion 67-8. 2005
    ..This seems not to significantly influence the overall survival, probably because of a prompt and effective treatment of the recurrences themselves...
  15. ncbi Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial
    John P Pierce
    Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA 92093 0901, USA
    JAMA 298:289-98. 2007
    ..Evidence is lacking that a dietary pattern high in vegetables, fruit, and fiber and low in total fat can influence breast cancer recurrence or survival...
  16. ncbi Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials
    Irene L Wapnir
    National Surgical Adjuvant Breast and Bowel Project Operations Office and Biostatistical Center, Pittsburgh, PA, USA
    J Clin Oncol 24:2028-37. 2006
    ..Locoregional failure after breast-conserving surgery is associated with increased risk of distant disease and death. The magnitude of this risk in patients receiving chemotherapy has not been adequately characterized...
  17. ncbi Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors
    Stefaan Mulier
    Department of Surgery, University Hospital of Mont-Godinne, Catholic University of Louvain, Yvoir, Belgium
    Ann Surg 242:158-71. 2005
    ..The short-term benefits of less invasiveness for the percutaneous route do not outweigh the longer-term higher risk of local recurrence...
  18. ncbi Radical perineal prostatectomy: cost efficient, outcome effective, minimally invasive prostate cancer management
    Michael J Harris
    Northern Institute of Urology, 1020 Sixth Street, Traverse City, MI 49684, USA
    Eur Urol 44:303-8; discussion 308. 2003
    ..This method of anatomic radical perineal prostatectomy has been developed to accomplish a minimally invasive method of achieving goals of disease control and preservation of genito-urinary functions...
  19. ncbi Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
    Hiroshi Imamura
    Division of Hepato Biliary Pancreatic Surgery, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    J Hepatol 38:200-7. 2003
    ..We conducted a retrospective cohort study to investigate factors to early and late phase recurrence of hepatocellular carcinoma (HCC)...
  20. ncbi Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial
    Hidefumi Aoyama
    Departments of Radiology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    JAMA 295:2483-91. 2006
    ..In patients with brain metastases, it is unclear whether adding up-front whole-brain radiation therapy (WBRT) to stereotactic radiosurgery (SRS) has beneficial effects on mortality or neurologic function compared with SRS alone...
  21. ncbi A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
    John P Neoptolemos
    Department of Surgery, Liverpool University, Liverpool, United Kingdom
    N Engl J Med 350:1200-10. 2004
    ..CONCLUSIONS: Adjuvant chemotherapy has a significant survival benefit in patients with resected pancreatic cancer, whereas adjuvant chemoradiotherapy has a deleterious effect on survival...
  22. ncbi Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial
    Heather A Jones
    Department of Radiation Oncology, University of Pittsburgh Cancer Center, Pittsburgh, PA, USA
    J Clin Oncol 27:4939-47. 2009
    ..To investigate the long-term impact of pathologic characteristics and an extra boost dose of 16 Gy on local relapse, for stage I and II invasive breast cancer patients treated with breast conserving therapy (BCT)...
  23. ncbi Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial
    C A M Marijnen
    Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    Int J Radiat Oncol Biol Phys 55:1311-20. 2003
    ..Here we evaluate the effect of radiotherapy on local recurrence rates in patients with different CRM involvements...
  24. ncbi Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer
    Takashi Yoshioka
    Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
    J Nucl Med 44:690-9. 2003
    ..The aim of this study was to evaluate the visual diagnostic accuracy of (18)F-FDG PET for advanced, metastatic, or recurrent gastric cancer and to generate semiquantitative values for lesions...
  25. ncbi Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma
    Tim F Cloughesy
    Department of Neurology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
    PLoS Med 5:e8. 2008
    ..Small, molecularly focused clinical studies offer the promise of the early definition of optimal biologic dose and patient population...
  26. ncbi Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
    R Tung-Ping Poon
    Centre of Liver Diseases, Department of Surgery, The University of Hong Kong Medical Centre, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
    Ann Surg 232:10-24. 2000
    ..To evaluate the current knowledge on the risk factors for recurrence, efficacy of adjuvant therapy in preventing recurrence, and the optimal management of recurrence after resection of hepatocellular carcinoma (HCC)...
  27. ncbi Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
    Antonio M Lacy
    Department of Surgery, Institut de Malalties Digestives, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain
    Lancet 359:2224-9. 2002
    ..Our study aimed to compare efficacy of LAC and open colectomy (OC) for treatment of non-metastatic colon cancer in terms of tumour recurrence and survival...
  28. ncbi Small cell carcinoma of the urinary bladder. The Mayo Clinic experience
    Nicholas W W Choong
    Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer 103:1172-8. 2005
    ..Adjuvant treatment is not indicated for patients with Stage II disease after radical cystectomy but should be considered for patients with Stage III and IV disease. Chemotherapy should be a platinum-based regimen...
  29. ncbi Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
    Phil Quirke
    Leeds University, Leeds, UK
    Lancet 373:821-8. 2009
    ..However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved...
  30. ncbi Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial
    Harry Bartelink
    Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:3259-65. 2007
    ..To investigate the long-term impact of a boost radiation dose of 16 Gy on local control, fibrosis, and overall survival for patients with stage I and II breast cancer who underwent breast-conserving therapy...
  31. ncbi A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit
    Arne Wibe
    University Hospital Trondheim, Trondheim, Norway
    Dis Colon Rectum 45:857-66. 2002
    ..CONCLUSION: A refinement of the surgical resection technique for rectal cancer can be achieved on a national level, the technique of total mesorectal excision can be widely distributed, and surgery alone can give good results...
  32. ncbi The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
    Jiyoung Rhee
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
    BMC Cancer 8:307. 2008
    ..We investigated the clinicopathologic characteristics and prognostic indicators of lymph node-negative TN breast cancer...
  33. ncbi Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    A Howell
    Christie Hospital, Manchester, UK
    Lancet 365:60-2. 2005
    ..Anastrozole should be the preferred initial treatment for postmenopausal women with localised hormone-receptor-positive breast cancer...
  34. ncbi Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data
    Thomas J Vogl
    Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Radiology 230:450-8. 2004
    ..To evaluate the local tumor control and survival data for magnetic resonance (MR) imaging-guided laser-induced interstitial thermotherapy (LITT) of colorectal liver metastases...
  35. ncbi The transcriptional repressor Snail promotes mammary tumor recurrence
    Susan E Moody
    Department of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Cancer Cell 8:197-209. 2005
    ..In aggregate, our observations strongly implicate Snail in the process of breast cancer recurrence...
  36. ncbi Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer
    Daniel Chua
    Department of Clinical Oncology, PB 115, Queen Mary Hospital, Pokfulam, Hong Kong, China
    Jpn J Clin Oncol 38:244-9. 2008
    ..We conducted a retrospective review of patients who received capecitabine for recurrent and metastatic NPC to further evaluate its clinical benefits...
  37. ncbi Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
    Graziella Filippini
    Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy
    Neuro Oncol 10:79-87. 2008
    ..The benefit of second surgery at recurrence is uncertain, and new trials are needed to assess its effectiveness. Chemotherapy with PCV or temozolomide seems to be a reasonable option at tumor recurrence...
  38. ncbi Treatment options for recurrent giant cell tumors of bone
    Maurice Balke
    Department of Orthopedic Surgery, University of Muenster, Albert Schweitzer Str 33, 48149, Munster, Germany
    J Cancer Res Clin Oncol 135:149-58. 2009
    ..The possible surgical procedures range from repeated intralesional curettage to wide resection...
  39. ncbi Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer
    Chew Wun Wu
    Department of Surgery, Taipei Veterans General Hospital, Shih Pai, Taipei 112, Taiwan
    World J Surg 27:153-8. 2003
    ..It is conceivable that the patterns of recurrence and the times to recurrence provide a biological basis for clinical monitoring of patients with the aim of modifying therapeutic modalities...
  40. ncbi A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Daniel T T Chua
    Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Pokfulam PB 115, Hong Kong SAR, China
    Oral Oncol 39:361-6. 2003
    ..Capecitabine is an effective salvage regimen in patients with recurrent and metastatic NPC. Capecitabine as a single agent or in combination with other chemotherapeutic agents or treatment modalities should be further studied in NPC...
  41. ncbi Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy
    Sankar J Kausik
    Department of Urology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Cancer 95:1215-9. 2002
    ..The benefit of adjuvant therapy in optimizing recurrence-free survival remains to be tested...
  42. ncbi Postoperative anatomic and pathologic findings at CT following gastrectomy
    Kyoung Won Kim
    Department of Radiology and the Institute of Radiation Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea
    Radiographics 22:323-36. 2002
    ....
  43. ncbi Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma
    Jean-Marc Regimbeau
    Department of Hepatobiliary and Digestive Surgery, Beaujon Hospital, University of Paris VII, Clichy, France
    Surgery 131:311-7. 2002
    ..Therefore, anatomical resection should be the treatment of choice and considered as the reference surgical treatment compared with other treatments...
  44. ncbi Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue
    J N Myers
    Department of Head and Neck Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 92:3030-6. 2001
    ....
  45. ncbi The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United King
    P D Kottaridis
    Department of Haematology, University College London, London, United Kingdom
    Blood 98:1752-9. 2001
    ..The suggestion is made that detection of a FLT3/ITD should be included as a routine test at diagnosis and evaluated for therapeutic management...
  46. ncbi Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
    Peter Swindle
    Department of Urology, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancer, New York, New York 10021, USA
    J Urol 174:903-7. 2005
    ..We evaluated the prognostic significance of PSMs using multiple methods of analysis accounting for patients who received adjuvant therapy...
  47. ncbi (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer
    Long Bang Chen
    Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, Jiangsu Province, China
    World J Gastroenterol 13:5025-9. 2007
    ..To evaluate the value of (18)F-DG PET/CT in detecting recurrence and/or metastasis of colorectal cancer (CRC)...
  48. ncbi A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer
    M Basaran
    University of Instanbul, Institute of Oncology, Medical Oncology Department, Turkey
    J Chemother 14:207-13. 2002
    ..Given this moderate response rate, it is unlikely that this combination (PC) might ultimately prove to be superior to standard treatment regimens in terms of significant survival advantage...
  49. ncbi Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
    R D Issels
    Department of Internal Medicine III, Klinikum Grosshadern Medical Center KGMC, Ludwig Maximilians University, Munich, Germany
    Eur J Cancer 37:1599-608. 2001
    ..OS which did not differ for extremity versus non-extremity STS (P=0.21) was better for patients responding to EIA combined with RHT (P<0.01)...
  50. ncbi Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients
    Luca G Campana
    Department of Oncological and Surgical Sciences, Istituto di Clinica Chirurgica Generale II, Policlinico Universitario, 6 degrees Piano Via Giustiniani 2, 33128, Padova, Italy
    Ann Surg Oncol 16:191-9. 2009
    ..This benefit, although preliminary, deserves further assessment after a formal validation of the dedicated questionnaire...
  51. ncbi Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency Vancouver Island Centre and University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 61:1337-47. 2005
    ....
  52. ncbi Significance of microvascular density (MVD) in cervical cancer recurrence
    D Cantu de Leon
    Department of Gynecologic Oncology Clinical Research, Instituto Nacional de Cancerología de México
    Int J Gynecol Cancer 13:856-62. 2003
    ..0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival...
  53. ncbi Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
    K Khanfir
    Department of Radiotherapy, Institut Gustave Roussy, 94805 Villejuif, France
    Eur J Cancer 39:1872-80. 2003
    ....
  54. ncbi Salvage therapy in patients with glioblastoma: is there any benefit?
    Peter Hau
    Klinik und Poliklinik für Neurologie der Universität Regensburg im Bezirksklinikum, Regensburg, Germany
    Cancer 98:2678-86. 2003
    ..Their objectives were to improve patients' overall survival with sustained quality of life and to make comparisons with overall survival in unselected patients...
  55. ncbi Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
    M K B Parmar
    Lancet 361:2099-106. 2003
    ..INTERPRETATION: Paclitaxel plus platinum chemotherapy seems to improve survival and progression-free survival among patients with relapsed platinum-sensitive ovarian cancer compared with conventional platinum-based chemotherapy...
  56. ncbi Glioblastoma with lymph node metastases
    Lora Esberk Ates
    Istanbul University, Istanbul Medicine Faculty, Department of Pathology, Istanbul, Turkey
    Neuropathology 23:146-9. 2003
    ..We present a 40-year-old-man with glioblastoma multiforme metastasizing to the supraclavicular lymph node after surgery. The tumor was located at the parietal convexity and several lymphadenopathies occured after surgery...
  57. ncbi The Swedish rectal cancer registry
    L Pahlman
    Department of Surgery, University Hospital, Uppsala, Sweden
    Br J Surg 94:1285-92. 2007
    ..An audit of all patients with rectal cancer in Sweden was launched in 1995. This is the first report from the Swedish Rectal Cancer Registry (SRCR)...
  58. ncbi Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence
    A D Norden
    Department of Neurology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, SW430B, 44 Binney St, Boston, MA 02115, USA
    Neurology 70:779-87. 2008
    ..At recurrence some patients appear to develop nonenhancing infiltrating disease rather than enhancing tumor...
  59. ncbi Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project
    C S Trovik
    Department of Orthopedics, Haukeland University Hospital, Bergen, Norway
    Acta Orthop Scand Suppl 72:1-31. 2001
    ..The most effective way of reducing costs and detriment associated with local recurrence is to increase referral to sarcoma centers before biopsy or surgery as primary surgical margins would then improve...
  60. ncbi Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01
    R Porschen
    Department of Gastroenterology, University of Tubingen, Tubingen, Germany
    J Clin Oncol 19:1787-94. 2001
    ..The impact of 5-FU plus leucovorin on survival and tumor recurrence was analyzed in comparison with the effects of 5-FU plus levamisole in the prospective multicentric trial adjCCA-01...
  61. ncbi Effective surgical adjuvant therapy for high-risk rectal carcinoma
    J E Krook
    Duluth Community Clinical Oncology Program, Minn
    N Engl J Med 324:709-15. 1991
    ..We designed a combination regimen to optimize the contribution of chemotherapy, decrease recurrence, and improve survival as compared with adjuvant radiation alone...
  62. ncbi Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution
    Carlo Cappelli
    Department of Medical and Surgical Sciences, Internal Medicine and Endocrinology Unit, University of Brescia, Italy
    Ann Ital Chir 77:107-13. 2006
    ..To test the prognostic significant of clinicopathologic factors in patients affected by well-differentiated thyroid carcinoma (WDTC)...
  63. ncbi Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy
    Kimberly M Dalal
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10021, USA
    Ann Surg Oncol 14:1934-42. 2007
    ..An understanding of the pattern of recurrence after SLNB is helpful in coordinating a rational plan of follow-up in these patients. We sought to determine the site and timing of initial recurrence and post-recurrence survival after SLNB...
  64. ncbi Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Min Yao
    Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa Health Care, Iowa City, IA 52242, USA
    Int J Radiat Oncol Biol Phys 68:707-13. 2007
    ....
  65. ncbi [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]
    E Deniaud-Alexandre
    , , APHP, 4, rue de la Chine, 75970 Paris Cedex 20, France
    Cancer Radiother 10:572-82. 2006
    ..For patients with T3 or T4 lesion and tumor regression <or=50% after the first course of radiation therapy, surgical non conservative treatment should be discussed...
  66. ncbi Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy
    Peter Kornprat
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 14:1151-60. 2007
    ..Despite an unknown benefit, hepatic resection is playing an increasing role in patients with extensive disease...
  67. ncbi [Neck dissection for stage N0 oral cavity carcinoma]
    F Jegoux
    Service d ORL et Chirurgie Maxillo faciale, CHU Pontchaillou, rue Henri Le Guillou, 35033 Rennes Cedex 9
    Ann Otolaryngol Chir Cervicofac 123:221-6. 2006
    ..The management of N0 neck remains controversial. The purpose of this study was to evaluate the efficacy of selective neck dissection (SND) in managing N0 neck of oral cavity carcinomas...
  68. ncbi A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density
    Chi W Cheng
    Department of Surgery and Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
    Int Braz J Urol 32:536-49. 2006
    ..We studied the long-term outcome of radical cystectomy for transitional cell carcinoma and evaluated prognostic factors for disease specific survival...
  69. ncbi P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors
    Wassim Kassouf
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Eur Urol 52:769-74. 2007
    ..To improve our understanding of its significance in a contemporary series, we performed an outcomes analysis of this cohort of patients...
  70. ncbi Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study
    I L Atahan
    Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey
    Int J Gynecol Cancer 17:833-42. 2007
    ..The combination of EBRT and HDR BRT together with concomitant chemotherapy in the treatment of locally advanced carcinoma of cervix is safe and well tolerated with acceptable morbidity...
  71. ncbi Impact of clinicopathological parameters in patients treated for renal cell carcinoma
    Marcos F Dall'oglio
    Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Urol 177:1687-91. 2007
    ..We determined the impact of clinical and pathological factors in the outcome of patients with renal cell carcinoma treated surgically...
  72. ncbi Squamous-cell carcinoma of the anal canal: predictors of treatment outcome
    Ramin Roohipour
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Dis Colon Rectum 51:147-53. 2008
    ..The incidence of anal canal squamous-cell carcinoma is increasing. Limited data exist on predictors of treatment failure. This study was designed to identify predictors for relapse/persistence after first-line therapy...
  73. ncbi Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis
    Toshifumi Wakai
    Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata City, 951 8510, Japan
    Ann Surg Oncol 15:2472-81. 2008
    ..This study sought to clarify the distribution of intrahepatic micrometastases and elucidate an adequate hepatectomy margin for colorectal carcinoma liver metastases...
  74. ncbi Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience
    L Montella
    San Giovanni di Dio Hospital, Naples, Italy
    Oncol Rep 20:385-90. 2008
    ..Statistically significant correlation was found between serum VEGF and tumor progression. In conclusion, the combination of RFA and octreotide was active in advanced HCC, however, confirmation in a larger series is required...
  75. ncbi Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
    G Ryan
    Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
    Ann Oncol 19:233-41. 2008
    ..Primary diffuse large B-cell lymphoma (DLBCL) of breast is rare. We aimed to define clinical features, prognostic factors, patterns of failure, and treatment outcomes...
  76. ncbi An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model
    Q D Pieterse
    Department of Gynaecology, Leiden University Medical Center, Leiden, The Netherlands
    Int J Gynecol Cancer 18:432-8. 2008
    ..This possibility is an important step forward to improve the quality of cancer care...
  77. ncbi Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent
    K Narayan
    Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
    Int J Gynecol Cancer 18:525-33. 2008
    ..In the presence of these factors, clinical tumor diameter and FIGO stage were not significantly related to risk of any type of failure...
  78. ncbi Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma
    Mi Sook Kim
    Department of Radiation Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Nowon Gu, Seoul, Republic of Korea
    Jpn J Clin Oncol 38:695-700. 2008
    ..To investigate the clinical applications of stereotactic body radiation therapy (SBRT) using the CyberKnife system for pelvic recurrence from rectal cancer with a focus on survival and toxicity...
  79. ncbi Peritoneal cytology in colorectal cancer: incidence and prognostic value
    Ugur Gozalan
    4th Department of Surgery, Ankara Numune Education and Research Hospital, 06500, Ankara, Turkey
    Am J Surg 193:672-5. 2007
    ..The value of peritoneal washing cytology on prognosis is not clear yet. The aims of our prospective study were to consider the incidence and prognostic value of peritoneal cytology...
  80. ncbi Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy
    Yohei Horikawa
    Department of Urology, Akita University School of Medicine, 1 1 1 Hondo, Akita 010 8543, Japan
    Int J Clin Oncol 12:131-6. 2007
    ....
  81. ncbi Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology
    J Emmering
    Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands
    Ann Oncol 19:1573-7. 2008
    ....
  82. ncbi [The impact of the extent and time of operation on the survival in patients with differentiated thyroid carcinoma (DTC)]
    Agnieszka Czarniecka
    Centre of Oncology, Maria Sklodowska Curie Memorial Institute, Branch Gliwice, Gliwice
    Endokrynol Pol 57:347-55. 2006
    ..To analyze the impact of time and extent of operation on overall and disease-free survival in patients with differentiated thyroid carcinoma (DTC)...
  83. ncbi Local control of piriform sinus cancer treated by radiation therapy alone
    J Itami
    Department of Radiation Therapy and Oncology, International Medical Center of Japan, Shinjuku-ku, Tokyo
    Acta Oncol 36:389-92. 1997
    ..In addition to the T-stage, other tumor factors should also be considered for predicting local control with radiation therapy...
  84. ncbi Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome
    Kent G Krejci
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 62:641-6. 2003
    ..Tumor stage and grade were associated with outcome among patients with localized clear cell RCC. These findings are similar to the results for patients with localized clear cell RCC treated with radical nephrectomy...
  85. ncbi Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors
    Josef Zamecnik
    Department of Pathology and Molecular Medicine, Charles University, 2nd Medical School, Prague, Czech Republic
    Mod Pathol 16:980-91. 2003
    ..Foci of hypercellularity should be specifically looked for in ependymomas for assessing the immunohistochemical studies...
  86. ncbi Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome
    Richard W Tsang
    Department of Radiation Oncology and Biostatistics, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    J Clin Oncol 21:4157-64. 2003
    ..We report the clinical outcome of stage I and II MALT lymphoma treated with involved field radiation therapy (RT)...
  87. ncbi [Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types]
    S Euteneuer
    Klinik fur Hals, Nasen, Ohrenheilkunde, Kopf und Halschirurgie der Ruhr Universität Bochum, Germany
    Laryngorhinootologie 83:33-9. 2004
    ..Malignomas of the nasal cavity and the paranasal sinuses count for less than 3 % of the ENT-malignancies...
  88. ncbi Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension
    Abderrahim Zouhair
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Strahlenther Onkol 180:84-90. 2004
    ..In case of anterior commissure extension, surgery or higher RT doses are warranted. Because of a high relapse risk, arytenoid protection should not be attempted...
  89. ncbi Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    Anthony W Fyles
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    N Engl J Med 351:963-70. 2004
    ..We determined the effect of breast irradiation plus tamoxifen on disease-free survival and local relapse in women 50 years of age or older who had T1 or T2 node-negative breast cancer...
  90. ncbi Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment
    Hiroyuki Sakurai
    Second Department of Surgery, University of Yamanashi, Yamanashi, Japan
    Ann Thorac Surg 78:1728-33. 2004
    ..In this retrospective study, we investigated the pattern of recurrence and survival outcome for patients with resected BAC by pathology review, compared with those in patients who had adenocarcinoma other than BAC...
  91. ncbi Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance
    D Massi
    Department of Human Pathology and Oncology, University of Florence, Viale G.B. Morgagni 85, 50134 Florence, Italy
    Eur J Surg Oncol 30:1131-6. 2004
    ..In our experience, AJCC stage and myogenic differentiation are the factors which independently affect prognosis...
  92. ncbi [Results of cervical cancer treatment at the Lower Silesian Oncology Center between 1987 and 1989]
    Jacek Dryl

    Ginekol Pol 73:1184-91. 2002
    ..Brachytherapy with cesium resulted in improved SR of 50.9% compared with radium (39.8%). CONCLUSION: Based on obtained data, the factors of prognostic value are: stage of disease, age and treatment...
  93. ncbi Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder
    David Ramos
    Department of Pathology, University of Valencia Medical School, Valencia, Spain
    Cancer 97:1876-83. 2003
    ..The differential expression patterns of cytokeratin 20 (CK20) and 34betaE12 antigen in low-grade papillary urothelial tumors of the bladder are discussed...
  94. ncbi Nasopharyngeal carcinoma: clinical assessment and review of 176 cases
    M August
    Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Boston, MA 02114, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:205-14. 2001
    ..CONCLUSIONS: Being attuned to the presenting signs of NPC may lead to a more expedient diagnosis. The differing risk factors associated with WHO 1 tumors become clear in this predominantly white population...
  95. ncbi Treatment of carcinoma of the parotid gland: the results of a multicenter study
    A Tullio
    Department of Maxillo-Facial Surgery, Hospital of Parma, Italy
    J Oral Maxillofac Surg 59:263-70. 2001
    ..CONCLUSIONS: Postoperative irradiation is indicated for patients with stage III and IV disease, patients with positive excision margins, and for patients with lymph node metastases...
  96. ncbi Breast-conserving therapy for ductal carcinoma in situ
    A Takeda
    Department of Radiology, School of Medicine, Keio University, 35-Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
    Oncol Rep 8:835-9. 2001
    ..103). The 12 recurrent cases underwent additional surgery and all remain alive without recurrence, to date, i.e., at least 16 months. Breast-conserving surgery plus irradiation is appropriate treatment for DCIS patients...
  97. ncbi Local excision and postoperative radiotherapy for distal rectal cancer
    R Benson
    Department of Oncology, Addenbrooke's Hospital, United Kingdom, Cambridge, UK
    Int J Radiat Oncol Biol Phys 50:1309-16. 2001
    ..Patients with LVI or tumor fragmentation during excision have high local relapse rates and may not be good candidates for conservative surgery and postoperative RT...
  98. ncbi Adenoid cystic carcinoma of the head and neck
    S Chummun
    The Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK
    Br J Plast Surg 54:476-80. 2001
    ..Positive margins, perineural invasion and solid histology of ACC were associated with increased morbidity and treatment failure. Patients treated with combined therapy did better than those who underwent a single treatment modality...
  99. ncbi High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999
    Peter Sykes
    Department of Obstetrics and Gynaecology, Christchurch School of Medicine, New Zealand
    Aust N Z J Obstet Gynaecol 42:69-74. 2002
    ..The true rate of malignant progression in untreated patients remains unclear and radical surgery is rarely indicated. All patients require long-term follow up...
  100. ncbi Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature
    Antonio B Porcaro
    Cattedra e Divisione Clinicizzata di Urologia, Ospedale Policlinico G.B. Rossi, Verona, Italy
    Arch Ital Urol Androl 74:81-5. 2002
    ..Ongoing clinical trials for testicular germ cell metastatic disease are focused on reducing toxicity without compromising efficacy as well as exploring new salvage strategies and improving the prospect of cures and survival rates...

Research Grants143 found, 100 shown here

  1. Strategies Against HPV Related Genital Diseases in Women
    Bradley Monk; Fiscal Year: 2006
    ..It is expected that Dr. Monk will have obtained extramural funding for both his laboratory and clinical studies by the end of the period of support requested. ..
  2. Methodology of Phase I and II trials of anticancer CAM
    Andrew Vickers; Fiscal Year: 2004
    ....
  3. Biobehavioral Responses to Cancer
    BARBARA ANDERSEN; Fiscal Year: 2007
    ..abstract_text> ..
  4. Defibrotide for the treatment of severe hepatic veno-cc*
    Paul Richardson; Fiscal Year: 2007
    ..Abstract Not Provided ..
  5. PSYCHOLOGICAL INTERVENTION FOR WOMEN WITH BREAST CANCER
    BARBARA ANDERSEN; Fiscal Year: 2005
    ....
  6. Phase II Study of 44Gy from 131I-81C6 for CNS Tumors
    David Reardon; Fiscal Year: 2004
    ..To further define the toxicity of this approach and Specific Aim 3.To determine the impact of this therapy on quality of life. ..
  7. Human Breast Cancer Stem Cell Surrogates
    WENDY A contact WOODWARD; Fiscal Year: 2010
    ..This approach could be used to select patients for individualized therapy using targeted sensitizing agents based on the proposed preclinical studies. ..
  8. Human Breast Cancer Stem Cell Surrogates
    Massimo Cristofanilli; Fiscal Year: 2009
    ..This approach could be used to select patients for individualized therapy using targeted sensitizing agents based on the proposed preclinical studies. ..
  9. Human Breast Cancer Stem Cell Surrogates
    Massimo Cristofanilli; Fiscal Year: 2009
    ..This approach could be used to select patients for individualized therapy using targeted sensitizing agents based on the proposed preclinical studies. ..
  10. Genetic and Epigenetic Markers in Ovarian Cancer
    Elizabeth Swisher; Fiscal Year: 2006
    ..These studies may identify new prognostic or diagnostic markers in ovarian cancer. Such markers could then be tested in prospective trials to determine their clinical utility. ..
  11. Vitamin D in Prostate Cancer: Tumor Vasculature Effects
    Donald Trump; Fiscal Year: 2006
    ....
  12. HPV-Specific, Immune Suppression in Patients with RRP
    VINCENT ROBERT BONAGURA; Fiscal Year: 2010
    ..mild/moderate disease. These studies will identify immune system cells that inappropriately respond to HPV, help develop a therapeutic vaccine, and new strategies to treat patients with RRP. ..
  13. VEGF Function in B-CLL
    Neil E Kay; Fiscal Year: 2010
    ..3) Does the VEGF/VEGF-R pathway(s) found in CLL B cells correlate with either clinical and/or critical biologic parameters in B-CLL? ..
  14. Fiber and Colorectal Adenomas: A Pooling Project
    Elizabeth Jacobs; Fiscal Year: 2005
    ..If it is found that certain groups may receive greater benefit from fiber, then public health recommendations can be made which target these groups and prevent the recurrence of colorectal adenomas. ..
  15. VEGF Function in B-CLL
    Neil Kay; Fiscal Year: 2007
    ..3) Does the VEGF/VEGF-R pathway(s) found in CLL B cells correlate with either clinical and/or critical biologic parameters in B-CLL? ..
  16. Tea Modulation of Colon Carcinogenesis
    Michael Wargovich; Fiscal Year: 2010
    ..Because RXRa loss involves impairment of regulatory gene networks, the impact of green tea reversal of this transcription factor's loss is significant. ..
  17. AGT DEPLETION FOR THERAPY OF CNS TUMORS
    Jennifer Quinn; Fiscal Year: 2004
    ..abstract_text> ..
  18. Design and Validation of a Biomarker-enhanced System to Predict RCC Progression
    Alexander S Parker; Fiscal Year: 2010
    ....
  19. MENTORING & ADVANCED RESEARCH TRAINING FOR WRHR SCHOLARS
    Jonathan Berek; Fiscal Year: 2007
    ..This cadre of Scholars will be among future leaders in women's reproductive health research in the United States. ..
  20. Gene Transfer to Facilitate Dose-Intensification in the Treatment of Pediatric B*
    Lars Wagner; Fiscal Year: 2007
    ..We hypothesize this strategy will be well tolerated and allow for meaningful dose escalation through chemoprotection afforded by gene transfer into hematopoietic stem cells. ..
  21. Nitric oxide as a target for dietary intervention in colitis
    Michael Wargovich; Fiscal Year: 2007
    ..The overall goal of this application is to provide the public some assurance that the dietary supplements gingko and ginseng, have the capacity to alleviate colitis. ..
  22. Markers for the Early Detection of Ovarian Cancer
    MICHAEL TAINSKY; Fiscal Year: 2007
    ..The principle is that we clone epitopes reacting with IgG in patients sera and use them to detect antibodies in sera to discriminate cancer and healthy subjects and whether we can detect disease prior to standard diagnosis. ..
  23. Better Breast Health for Korean American Women
    Hae Ra Han; Fiscal Year: 2006
    ....
  24. CHILDRENS NATIONAL MEDICAL CENTER
    Roger Packer; Fiscal Year: 2003
    ....
  25. Obesity and Outcomes After Early Stage Breast Cancer
    James Dignam; Fiscal Year: 2003
    ..These investigations will provide valuable information for current patient management and insights into appropriate prospective interventions to improve breast cancer survivorship. ..
  26. ITEM BANKING AND CAT FOR QUALITY OF LIFE OUTCOMES
    David Cella; Fiscal Year: 2007
    ..We will also monitor treatment/management changes, and evaluate acceptability of computer assessments and the perceived benefits of the recommendations. ..
  27. Ultrastaging of Early Colon Cancer
    Anton Bilchik; Fiscal Year: 2009
    ....
  28. Sentinel Node Versus Axillary Dissection in Breast Cancer
    David Krag; Fiscal Year: 2007
    ....
  29. Cancer Prevention by West African Medicinal Plants
    Michael Wargovich; Fiscal Year: 2007
    ..We have unique access to actual plants with purported anti-inflammatory activity used by actual traditional healers in West Africa. ..
  30. Sentinel Node Versus Axillary Dissection in Breast Cancer
    David Krag; Fiscal Year: 2009
    ....
  31. TARGETING BREAST CANCER WITH SMALL LIGANDS
    David Krag; Fiscal Year: 2001
    ..Specifically, this work will produce lead compounds for drugs with great potential efficacy in the treatment of breast cancer. ..
  32. Proapoptotic Therapy for B-cell Non Hodgkin's Lymphoma
    Ajay Gopal; Fiscal Year: 2007
    ..The results of this project will be critical to the future development of this therapy and potentially lead to a novel, practical, inexpensive, well-tolerated, oral method to optimize the efficacy of anti-CD20 therapy for B-NHL. ..
  33. NIH PROMIS Statistical Coordinating Center(RMI)
    David Cella; Fiscal Year: 2007
    ..This collaborative effort will ensure the success of the PROMIS initiative. ..
  34. Targeted Enzymes for Prodrug Therapy
    David Krag; Fiscal Year: 2007
    ..Successful completion of these experiments will result in demonstration of novel targeted effector molecules that bind selectively to tumors and activate cytotoxic prodrugs. ..
  35. SOMATIC GENETIC CHANGES IN EARLY BREAST CANCER
    Joseph Geradts; Fiscal Year: 2005
    ..Lastly, our study explores the utility of high resolution aCGH as a clinically useful assay. ..
  36. ITEM BANKING AND CAT FOR QUALITY OF LIFE OUTCOMES
    David Cella; Fiscal Year: 2004
    ..abstract_text> ..
  37. OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA
    Ajay Gopal; Fiscal Year: 2005
    ..We anticipate that these interventions will ultimately enhance the prognosis for patients with relapsed lymphoma by increasing the response and survival rates, while simultaneously minimizing toxicities. ..
  38. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2004
    ..This proposed approach may ultimately improve the selection of patients for adjuvant therapy following resection of early-stage colon cancer. ..
  39. In Vivo Selection of Ligands for Targeted Therapy
    David Krag; Fiscal Year: 2003
    ..Successful completion of this clinical study will result in demonstration of a satisfactory safety profile and short peptides that bind selectively to tumor tissue. ..